BEIGENE Trademark

Trademark Overview


On Thursday, April 15, 2021, a trademark application was filed for BEIGENE with the United States Patent and Trademark Office. The USPTO has given the BEIGENE trademark a serial number of 90647320. The federal status of this trademark filing is REGISTERED as of Tuesday, September 27, 2022. This trademark is owned by BeiGene, Ltd.. The BEIGENE trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design

Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medi...

Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases

Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice
beigene

General Information


Serial Number90647320
Word MarkBEIGENE
Filing DateThursday, April 15, 2021
Status700 - REGISTERED
Status DateTuesday, September 27, 2022
Registration Number6860858
Registration DateTuesday, September 27, 2022
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements


Description of MarkThe mark consists of a shaded square in red with a stylized red square and a star cutout in the center of the stylized square to the left of the black wording "BeiGene" with a red arrow as part of the letter "G.
Indication of Colors claimedThe color(s) red and black is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design
Goods and ServicesPharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
Goods and ServicesCustom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
Goods and ServicesTelemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 22, 2021
Primary Code005
First Use Anywhere DateMonday, September 20, 2021
First Use In Commerce DateMonday, September 20, 2021

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, July 22, 2021
Primary Code040
First Use Anywhere DateMonday, September 20, 2021
First Use In Commerce DateMonday, September 20, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 22, 2021
Primary Code042
First Use Anywhere DateMonday, September 20, 2021
First Use In Commerce DateMonday, September 20, 2021

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 22, 2021
Primary Code044
First Use Anywhere DateMonday, September 20, 2021
First Use In Commerce DateMonday, September 20, 2021

Trademark Owner History


Party NameBEONE MEDICINES I GMBH
Party Type33 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressBASEL 4051
CH

Party NameBG NC 1, LTD.
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressGRAND CAYMAN 1-1108
KY

Party NameBEONE MEDICINES LTD.
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressBASEL 4051
CH

Party NameBeiGene, Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSan Mateo, CA 94404

Party NameBeiGene, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGrand Cayman KY1-1108
KY

Party NameBeiGene, Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGrand Cayman KY1-1108
KY

Trademark Events


Event DateEvent Description
Monday, April 19, 2021NEW APPLICATION ENTERED
Thursday, July 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 23, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, September 8, 2021ASSIGNED TO EXAMINER
Monday, September 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 12, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, May 26, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 12, 2022USE AMENDMENT FILED
Thursday, May 26, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 1, 2022ASSIGNED TO LIE
Wednesday, June 1, 2022DATA MODIFICATION COMPLETED
Thursday, July 7, 2022SU - NON-FINAL ACTION - WRITTEN
Thursday, July 7, 2022NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 11, 2022SU - FINAL REFUSAL - WRITTEN
Thursday, August 11, 2022FINAL REFUSAL E-MAILED
Thursday, August 11, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, August 18, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, August 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 22, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 23, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 27, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, September 27, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, December 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 9, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, July 10, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 29, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 29, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP